Uno Takashi, Sumi Minako, Ishihara Yoshitomo, Numasaki Hodaka, Mitsumori Michihide, Teshima Teruki
Department of Radiology, Chiba University Graduate School of Medicine, Chiba, Japan.
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):414-9. doi: 10.1016/j.ijrobp.2007.10.018. Epub 2007 Dec 31.
This study was undertaken to analyze the practice process of thoracic radiotherapy (TRT) and evaluate changes in patterns of care for patients with limited-stage small-cell lung cancer (LS-SCLC) in Japan.
The Patterns of Care Study (PCS) conducted the second nationwide survey of care process for patients with LS-SCLC treated by using TRT between 1999 and 2001.
The PCS collected data for 139 patients with LS-SCLC (man-woman ratio, 5:1; median age, 69 years; age > 70 years, 43%; Karnofsky Performance Status > 70, 73%; and Stage III, 88%). Median total dose was 50 Gy. Twice-daily TRT was used in 44% of patients. Median field size was 12 x 14 cm. The most commonly used photon energy was 10 MV (77%), whereas obsolete techniques using (60)Co or X-ray energy less than 6 MV comprised 12%. Three-dimensional conformal therapy was used with 12% of patients. Computed tomography simulation was performed in 40% of cases. Only 12 patients (8.6%) received prophylactic cranial irradiation (PCI). Concurrent chemotherapy and TRT (CCRT) was used for 94 patients (68%). Only 6 patients (4.4%) entered clinical trials. Compared with the previous PCS 95-97, significant increases in the use of CCRT (34-68%; p < 0.0001), twice-daily TRT (15-44%; p < 0.0001), and PCI (1.7-8.6%; p =0.0045) were observed, although the absolute number of patients receiving PCI was still extremely low.
Evidence-based CCRT and twice-daily TRT has penetrated into clinical practice. However, PCI is not yet widely accepted in Japan.
本研究旨在分析胸段放疗(TRT)的实施过程,并评估日本局限期小细胞肺癌(LS-SCLC)患者的治疗模式变化。
模式照护研究(PCS)于1999年至2001年期间对采用TRT治疗的LS-SCLC患者的照护过程进行了第二次全国性调查。
PCS收集了139例LS-SCLC患者的数据(男女比例为5:1;中位年龄69岁;年龄>70岁者占43%;卡氏功能状态>70者占73%;Ⅲ期者占88%)。中位总剂量为50 Gy。44%的患者采用每日两次的TRT。中位照射野大小为12×14 cm。最常用的光子能量为10 MV(77%),而使用钴-60或能量小于6 MV的X射线等过时技术占12%。12%的患者采用三维适形放疗。40%的病例进行了计算机断层扫描模拟。仅12例患者(8.6%)接受了预防性脑照射(PCI)。94例患者(68%)采用同步化疗和TRT(CCRT)。仅6例患者(4.4%)进入临床试验。与之前的PCS 95 - 97相比,观察到CCRT(34 - 68%;p<0.0001)、每日两次的TRT(15 - 44%;p<0.0001)和PCI(1.7 - 8.6%;p = 0.0045)的使用显著增加,尽管接受PCI的患者绝对数量仍然极低。
基于证据的CCRT和每日两次的TRT已渗透到临床实践中。然而,PCI在日本尚未被广泛接受。